Related references
Note: Only part of the references are listed.Multifocal infection due to Mycobacterium intracellulare:: first case of interferon gamma receptor partial dominant deficiency in tropical French territory
M. Muszlak et al.
ARCHIVES DE PEDIATRIE (2007)
Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis
K. M. Antoniou et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease
Phung K. Lam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFN gamma R1 deficiency
Pawel Remiszewski et al.
RESPIRATION (2006)
Therapeutic efficacy of ozone in patients with diabetic foot
G Martínez-Sánchez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Anti-IFN-γ autoantibodies in disseminated nontuberculous mycobacterial infections
SY Patel et al.
JOURNAL OF IMMUNOLOGY (2005)
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease
DE Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Six-month therapy with aerosolized interferon-γ for refractory multidrug-resistant pulmonary tuberculosis
WJ Koh et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2004)
Naturally occurring anti-IFN-γ autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans
C Höflich et al.
BLOOD (2004)
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-γ deficiency
TS Hallstrand et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Mycobacterium avium complex pulmonary disease in patients without HIV infection
SK Field et al.
CHEST (2004)
Clinical features of dominant and recessive interferon γ receptor 1 deficiencies
SE Dorman et al.
LANCET (2004)
Increased advanced oxidation protein products in Behcet's disease:: a new activity marker?
C Yazici et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Adjuvant interferon gamma in patients with drug-resistant pulmonary tuberculosis:: a pilot study -: art. no. 44
R Suárez-Méndez et al.
BMC INFECTIOUS DISEASES (2004)
Mycobacterium tuberculosis and Mycobacterium avium modify the composition of the phagosomal membrane in infected macrophages by selective depletion of cell surface-derived glycoconjugates
R Pietersen et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2004)
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome
CA Benson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Release of biologically active TGF-β1 by alveolar epithelial cells results in pulmonary fibrosis
YD Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Anti-inflammatory properties of pro-inflummatory interferon-γ
H Mühl et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Oxidative stress and gene expression in sepsis
J Macdonald et al.
BRITISH JOURNAL OF ANAESTHESIA (2003)
Recent advances in the analysis of oxidized proteins
JR Requena et al.
AMINO ACIDS (2003)
Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteria
H Hale-Donze et al.
JOURNAL OF IMMUNOLOGY (2002)
Host susceptibility factors in mycobacterial infection - Genetics and body morphotype
SV Guide et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2002)
Share Paper
